| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 7,165 | $41.75 | $299,138.75 | View Details Filing |
| Apr 15, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 56,815 | $41.01 | $2,329,983.15 | View Details Filing |
| Apr 15, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 20 | $42.66 | $853.20 | View Details Filing |
| Apr 1, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 34,902 | $30.55 | $1,066,256.10 | View Details Filing |
| Apr 1, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 25,098 | $31.46 | $789,583.08 | View Details Filing |
| Feb 20, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 60,000 | $30.10 | $1,805,766.00 | View Details Filing |
| Feb 3, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 33,635 | $32.70 | $1,099,864.50 | View Details Filing |
| Feb 3, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 66,452 | $32.06 | $2,130,451.12 | View Details Filing |
| Jan 27, 2026 | Travere Therapeutics, Inc. (TVTX) | S | 51,865 | $30.10 | $1,560,980.91 | View Details Filing |